Birinapant Uses, Dosage, Side Effects and more
Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
| Trade Name | Birinapant |
| Generic | Birinapant |
| Birinapant Other Names | Birinapant |
| Type | |
| Formula | C42H56F2N8O6 |
| Weight | Average: 806.957 Monoisotopic: 806.429087881 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
